⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 18, 2025Future Integrative MedicineOpen Access

Traditional Chinese Medicine Combined with Peginterferon α-2b in Chronic Hepatitis B: A Real-world Cohort Study

Huiqing Liang Xiaoting Zheng Xiaowen Wu Luyun Zhang Yi Zheng Manying Zhang Min Hu Min Jia Yan Dai Shaodong Chen

View Full Paper

Ask AI

Bookmark

Share

Abstract

This is the authors' abstract. We don't add key points for this paper.

Peginterferon-α treatment exhibits low rates of the serological conversion rate of hepatitis B e antigen (HBeAg) and the negative conversion rate of hepatitis B virus (HBV) DNA, with significant myelosuppression leading to treatment discontinuation in some patients. Traditional Chinese medicine (TCM) may ameliorate liver inflammation and modulate immune responses. This study aims to investigate the efficacy of combining TCM with pegylated-interferon (PEG-IFN) α-2b and its impact on myelosuppression adverse effects.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Liang et al. (2025) studied this question.

synapsesocial.com/papers/6ab8a16503bafb67db1377c8 https://doi.org/10.14218/fim.2025.00020

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Treatment with Interferons (including Pegylated Interferons) in Patients with Hepatitis BOriginal Research · 2004 · 70 citations
2Alpha-interferon treatment in hepatitis BOriginal Research · 2017 · 88 citations
3Pegylated Interferon-based Treatment Improves Response Rates in Immune-tolerant Patients with Chronic Hepatitis B: A Prospective TrialCohort Study · 2026 · 1 citations
4Sequential combination of anti-PD-1 antibody and PEG-IFNα in chronic hepatitis B patients: correlates of HBsAg loss with enhanced T-cell responsesPilot Study · 2026
5Safety and efficacy of PD-1 antibody combined with pegylated interferon α for functional cure in nucleos(t)ide analogues-suppressed chronic hepatitis B patients: protocol for a multicentre randomised controlled trial2025 · 3 citations

Comparison of Peg-INF plus TDF versus TDF Monotherapy in Indeterminate-phase Chronic Hepatitis B Patients with High HBsAg levels, HBeAg-negative status, and Normal ALT Levels2026
Efficacy and safety of entecavir, peginterferon alfa-2b and GM-CSF combination therapy: the anchor randomized controlled trial2025
Efficacy and safety of entecavir, peginterferon alfa-2b and GM-CSF combination therapy: the anchor randomized controlled trial2025
Stratified Safety Evaluation Framework for Natural Products Based on New Approach Methodologies in Integrative Medicine: A Narrative ReviewFuture Integrative Medicine · 2026
The Impact of Tai Chi and Qigong on Non-motor Symptoms of Parkinson’s Disease: A Scoping Review of Randomized Controlled TrialsFuture Integrative Medicine · 2026

FMore from Future Integrative Medicine

More from Xiamen University

More from Xiamen University of Technology

More from Fujian University of Traditional Chinese Medicine

More from Ningde Normal University

More from Xiamen Chang Gung Hospital